Americas Gold and Silver Corporation (USAS) is a Toronto-based precious metals miner that produces silver and gold, along with zinc, lead, copper, and antimony, from the Galena Complex in Idaho and the Cosalá operations in Sinaloa, Mexico. Its shares trade on the NYSE American and the Toronto Stock Exchange.
The analyst picture here is unusually fragmented. After shares collapsed roughly 80% from their January 2026 peak above $10, most U.S.-dollar targets were not refreshed. The cleanest current data point is H.C. Wainwright's November 2026 cut to $6.75 from $9.25 (Buy rating), which matches the one-year target estimate currently listed on Yahoo Finance. In Canadian dollars, National Bank reaffirmed a C$10.00 target (Nov. 18, 2026) and Stifel Nicolaus a C$12.00 target (Nov. 16, 2026). Earlier USD targets — BMO at $8.54, TD Cowen at $9.26, and Canaccord Genuity near $11.39 — largely predate the selloff and now look stale. Because no reliable multi-analyst average exists among current, refreshed targets, $6.75 is used here as the central reference rather than an official consensus, which is why the target range should be read with caution. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
With the stock around $1.92, a move to $6.75 implies upside of about 250%, a very large move. The company reported fiscal third-quarter 2026 results on Nov. 13: revenue rose 68% year over year to $51.4 million but missed the roughly $68 million consensus estimate, and the company posted an adjusted loss of $0.02 per share. The quarter was a study in contrasts — record consolidated silver output of 800,458 ounces was driven by Cosalá, while the Galena complex grappled with higher contractor-driven costs and all-in sustaining costs (AISC, the cost to produce each ounce including sustaining capital) of $42.94 per ounce versus a $30–$35 guidance range. The stock trades well below its 50-day and 200-day moving averages, near its 52-week low.
Several fundamentals underpin the bullish case. Cosalá delivered 415,879 ounces of silver, up 28% year over year, with cash costs of about $14.51 per ounce after copper by-product credits, and management described high-grade intercepts "world-class." Galena hosts the largest antimony mine in the United States, and the company has a joint venture to build a domestic, integrated antimony supply chain — a strategic angle given antimony's use in defense and battery applications. Management also argues that hoisting and development upgrades at Galena will enable more efficient, higher-grade mining once the paste-fill plant is commissioned. A rebound in silver prices would directly boost revenue and margins. From what I see, this antimony angle adds a layer of strategic interest that many peers lack.
The obstacles are substantial. Full-year production is tracking toward the low end of the 3.2–3.6 million-ounce forecast, and AISC toward the high end of guidance, even though quarterly and year-to-date costs already exceed it. The Galena paste-fill plant slipped from a fourth-quarter 2026 to a hoped-for early 2027 start. Cash declined to $63.3 million from $122 million earlier in the year, and the company's own disclosures note that sustained negative operating cash flow could require debt or equity financing. Finally, the macro backdrop is unfavorable: a strong dollar, roughly 5% Treasury yields, and expectations of a December Federal Reserve rate increase have pushed silver toward 14-month lows, pressuring the entire silver-mining sector.
The stock is in a pronounced downtrend. Immediate support sits near the 52-week low in the $1.84–$2.02 zone. Overhead, the early-November breakdown low near $2.67 now marks initial resistance, followed by the 200-day moving average near $5.33 — far above the current price — and ultimately the 52-week high near $10.50. The distance between the current quote and even the 200-day average illustrates how much technical repair would be required before $6.75 becomes relevant.
Analyst price targets generally reflect a roughly 12-month research horizon, though that can vary by firm and is not a guarantee. Investors should watch fourth-quarter production and AISC against guidance, the Galena paste-fill plant timeline and 2027 guidance, the antimony joint venture, and cash/liquidity trends. Silver and gold prices, the U.S. dollar, Treasury yields, and Federal Reserve rate decisions will also materially influence sentiment and realized prices. I’m watching this closely as operational updates at Galena could shift the outlook quickly.
For traders who want a systematic view of shifting conditions, Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. The tool is designed to help traders discover opportunities, monitor positions, and spot changing trends more efficiently than manual scanning. Consider exploring it to complement your own research.
Can USAS reach $6.75? The target reflects the most recent post-earnings analyst view — H.C. Wainwright's cut to $6.75 from $9.25 — rather than a robust multi-analyst consensus, and it sits roughly 250% above the current price. The bull case rests on record production, exceptional Cosalá grades, and the antimony strategic angle; the bear case rests on above-guidance costs, a revenue miss, tightening liquidity, and a weak silver-price macro regime. With analyst targets fragmented and largely stale after the share collapse, the path to $6.75 would require not only operational improvement at Galena but a meaningful recovery in precious-metals prices. There are no guarantees, and investors should treat the wide target dispersion as a signal of genuine uncertainty.
In my own research process, I have found Tickeron's AI Screener helpful for quickly comparing USAS against peers on key metrics like production growth and cost trends. It allows for more efficient screening without replacing personal judgment on the fundamentals.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
The Aroon Indicator for USAS entered a downward trend on November 20, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 204 similar instances where the Aroon Indicator formed such a pattern. In 181 of the 204 cases the stock moved lower. This puts the odds of a downward move at 89%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on USAS as a result. In 66 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.
The Moving Average Convergence Divergence Histogram (MACD) for USAS turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 39 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where USAS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +11.53% 3-day Advance, the price is estimated to grow further. Considering data from situations where USAS advanced for three days, in 241 of 276 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
USAS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 26 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 49 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.530) is normal, around the industry mean (6.813). P/E Ratio (-18.176) is within average values for comparable stocks, (-0.701). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.026). Dividend Yield (0.000) settles around the average of (0.016) among similar stocks. P/S Ratio (7.905) is also within normal values, averaging (283.864).
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 92 (best 1 - 100 worst), indicating slightly worse than average price growth. USAS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. USAS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a miner for silver, gold, and other minerals
Industry OtherMetalsMinerals